Gijsbert Keja

Gijsbert holds a master in Medical biology, with a specialisation in Science, Management and Innovation. He will be driving the commercialization efforts of Epinn and CyclomicsSeq. Gijsbert brings valuable experience at GenDx, Radboudumc Holding and Van Lanschot Kempen Investment Banking. With this combination of molecular diagnostics, valorisation and life science investment banking, Gijsbert brings the ability to translate Cyclomics' groundbreaking technologies into compelling value propositions.